These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6106182)

  • 1. Defect in soluble tyrosine aminotransferase in skin fibroblasts of a patient with tyrosinemia.
    deGroot GW; Dakshinamurti K; Allan L; Haworth JC
    Pediatr Res; 1980 Jul; 14(7):896-8. PubMed ID: 6106182
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic tyrosine aminotransferase in tyrosinaemia type II.
    Kida K; Takahashi M; Fujisawa Y; Matsuda H; Machino H; Miki Y
    J Inherit Metab Dis; 1982; 5(4):229-30. PubMed ID: 6133036
    [No Abstract]   [Full Text] [Related]  

  • 3. Persistent tyrosinemia associated with low activity of tyrosine aminotransferase.
    Andersson S; Nemeth A; Ohisalo J; Strandvik B
    Pediatr Res; 1984 Jul; 18(7):675-8. PubMed ID: 6147810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical observations on so-called hereditary tyrosinemia.
    Gaull GE; Rassin DK; Solomon GE; Harris RC; Sturman JA
    Pediatr Res; 1970 Jul; 4(4):337-44. PubMed ID: 4393588
    [No Abstract]   [Full Text] [Related]  

  • 5. Soluble and mitochondrial forms of tyrosine aminotransferase. Relationship to human tyrosinemia.
    Fellman JH; Vanbellinghen PJ; Jones RT; Koler RD
    Biochemistry; 1969 Feb; 8(2):615-22. PubMed ID: 4389443
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatic enzymes of tyrosine metabolism in tyrosinemia II.
    Goldsmith LA; Thorpe J; Roe CR
    J Invest Dermatol; 1979 Dec; 73(6):530-2. PubMed ID: 41876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble tyrosine aminotransferase deficiency: an unusual cause of corneal ulcers.
    Burns RP
    Am J Ophthalmol; 1972 Mar; 73(3):400-2. PubMed ID: 4401188
    [No Abstract]   [Full Text] [Related]  

  • 8. Enzyme defect in a case of tyrosinemia type I, acute form.
    Furukawa N; Kinugasa A; Seo T; Ishii T; Ota T; Machida Y; Inoue F; Imashuku S; Kusunoki T; Takamatsu T
    Pediatr Res; 1984 May; 18(5):463-6. PubMed ID: 6145143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keratopathy in tyrosinemia.
    Burns RP; Gipson IK; Murray MJ
    Birth Defects Orig Artic Ser; 1976; 12(3):169-80. PubMed ID: 8172
    [No Abstract]   [Full Text] [Related]  

  • 10. A new variant form of hypertyrosinaemia due to 4-hydroxyphenylpyruvic acid oxidase deficiency.
    Endo F; Kitano A; Uehara I; Nagata N; Matsuda I; Shinka T; Kuhara T; Matsumoto I
    J Inherit Metab Dis; 1982; 5(4):237-8. PubMed ID: 6133038
    [No Abstract]   [Full Text] [Related]  

  • 11. Tyrosinemia II: lessons in molecular pathophysiology.
    Goldsmith LA
    Pediatr Dermatol; 1983 Jul; 1(1):25-34. PubMed ID: 6149527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New forms of hereditary tyrosinemia type II in mink: hepatic tyrosine aminotransferase defect.
    Christensen K; Henriksen P; Sørensen H
    Hereditas; 1986; 104(2):215-22. PubMed ID: 2876972
    [No Abstract]   [Full Text] [Related]  

  • 13. Microassay of tyrosine-amino transferase and p-hydroxyphenylpyruvic acid oxidase in mammalian liver and patients with hereditary tyrosinemia.
    Whelan DT; Zannoni VG
    Biochem Med; 1974 Jan; 9(1):19-31. PubMed ID: 4150247
    [No Abstract]   [Full Text] [Related]  

  • 14. Type I tyrosinemia: lack of immunologically detectable fumarylacetoacetase enzyme protein in tissues and cell extracts.
    Berger R; Van Faassen H; Taanman JW; De Vries H; Agsteribbe E
    Pediatr Res; 1987 Oct; 22(4):394-8. PubMed ID: 3317254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary tyrosinemia type I: lack of correlation between clinical findings and amount of immunoreactive fumarylacetoacetase protein.
    Kvittingen EA; Rootwelt H; van Dam T; van Faassen H; Berger R
    Pediatr Res; 1992 Jan; 31(1):43-6. PubMed ID: 1594329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosinosis (tyrosinaemia).
    Jaiswal RB
    Indian Pediatr; 1975 Mar; 12(3):209-10. PubMed ID: 239906
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful dietary control of tyrosinemia II.
    Machino H; Miki Y; Kawatsu T; Kida K; Matsuda H
    J Am Acad Dermatol; 1983 Oct; 9(4):533-9. PubMed ID: 6195199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tyrosinemia II].
    Kalimo K; Ivaska K; Koistinen T; Havu VK
    Duodecim; 1985; 101(16):1585-9. PubMed ID: 2865123
    [No Abstract]   [Full Text] [Related]  

  • 19. Tyrosinemia II.
    Goldsmith LA
    Int J Dermatol; 1985 Jun; 24(5):293-4. PubMed ID: 2862113
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hereditary tyrosinemia type II].
    Endo F
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):134-6. PubMed ID: 9590007
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.